Since a recent study indicated that IL-6 drives ROS reduction by increasing Nrf 2, a transcription activator of the HO-1 gene, expression in human islet β-cells [51], further investigations into the role of IL-6–HO-1 crosstalk in hepatoma cells, in terms of ROS synthesis, are warranted. This evidence concerns the gene IL6 and hepatocellular carcinoma.